| RS2144578905 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144579011 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144579715 |
COL1A1
|
Health Risk |
Pathogenic |
Ovarian serous cystadenocarcinoma, Osteogenesis imperfecta type I |
| RS2144579745 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS2144579869 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144579919 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta type I |
| RS2144580035 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144580551 |
CIITA
|
Health Risk |
Pathogenic/Likely pathogenic |
MHC class II deficiency, Rheumatoid arthritis |
| RS2144580715 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS2144580791 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144581296 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144581824 |
AXIN2
|
Health Risk |
Pathogenic |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS2144581910 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS2144582186 |
KRT14
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 1A, generalized severe |
| RS2144582634 |
AXIN2
|
Health Risk |
Pathogenic |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS2144582778 |
AXIN2
|
Health Risk |
Pathogenic |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS2144582937 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2144583557 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS2144584155 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta type I |
| RS2144584170 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144585275 |
AXIN2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2144585785 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144585835 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144586064 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144586155 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144586769 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144586877 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144587059 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144587073 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144587690 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144587699 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS2144587770 |
AXIN2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Oligodontia-cancer predisposition syndrome |
| RS2144587960 |
AXIN2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Oligodontia-cancer predisposition syndrome |
| RS2144587964 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144588406 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS2144588834 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS2144588841 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144589016 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS2144589420 |
AXIN2
|
Health Risk |
Pathogenic |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS2144589643 |
AXIN2
|
Health Risk |
Likely pathogenic |
AXIN2-related attenuated familial adenomatous polyposis, AXIN2-related attenuated familial adenomatous polyposis |
| RS2144589822 |
AXIN2
|
Health Risk |
Pathogenic |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS2144590955 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144591295 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144591470 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144591532 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144591969 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS2144592269 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Ovarian cancer |
| RS2144592396 |
AXIN2
|
Health Risk |
Pathogenic |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS2144592402 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144592516 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144593648 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144593662 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144593670 |
COL1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144593675 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144593759 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, 8 conditions |
| RS2144594178 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144594472 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144594577 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144594663 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144594672 |
COL1A1
|
Health Risk |
Likely pathogenic |
— |
| RS2144594807 |
SLC4A1
|
Health Risk |
Pathogenic |
Autosomal dominant distal renal tubular acidosis, Autosomal dominant distal renal tubular acidosis |
| RS2144594835 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Cardiovascular phenotype |
| RS2144594870 |
COL1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type I |
| RS2144596313 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2144596569 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2144600020 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144600046 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144600397 |
COL1A1
|
Health Risk |
Likely pathogenic |
— |
| RS2144600428 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144600691 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS2144601154 |
SLC4A1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS2144601189 |
SLC4A1
|
Health Risk |
Likely pathogenic |
SLC4A1-related disorder, 11 conditions |
| RS2144601728 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2144601954 |
FA2H
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 35, Hereditary spastic paraplegia 35 |
| RS2144606157 |
FA2H
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 35, Hereditary spastic paraplegia 35 |
| RS2144607086 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
BLOOD GROUP--DIEGO SYSTEM, SLC4A1-related disorder |
| RS2144611947 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2144612096 |
SLC4A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2144613361 |
ADGRL1
|
Health Risk |
Pathogenic |
Attention deficit hyperactivity disorder, Global developmental delay |
| RS2144613733 |
ADGRL1
|
Health Risk |
Pathogenic |
Global developmental delay, Developmental delay |
| RS2144614170 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2144614196 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2144615066 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2144615077 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2144616263 |
ADGRL1
|
Health Risk |
Pathogenic |
Global developmental delay, Specific learning disability |
| RS2144616676 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2144616690 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2144616948 |
SLC4A1
|
Health Risk |
Likely pathogenic |
— |
| RS2144617221 |
FA2H
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2144617577 |
FA2H
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2144622191 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2144622461 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 52 |
| RS2144622488 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS2144622540 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS2144622620 |
STAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS2144622906 |
STAT3
|
Health Risk |
Likely pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS2144622987 |
STAT3
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS2144625053 |
POLRMT
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 55, Combined oxidative phosphorylation deficiency 55 |
| RS2144625139 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS2144625404 |
SMARCD2
|
Health Risk |
Pathogenic |
— |